Nanna N Nielsen, Jonas F Jensen, Andreas Øvlisen, Ditte R Zenas, Claudia Schöllkopf, Nina Toft, Andreas D Ørskov, Dennis L Hansen, Ingolf Mølle, Daniel T Kristensen, Marianne T Severinsen
{"title":"Reproductive patterns and birth rates in acute leukaemia survivors: A Danish population-based cohort study.","authors":"Nanna N Nielsen, Jonas F Jensen, Andreas Øvlisen, Ditte R Zenas, Claudia Schöllkopf, Nina Toft, Andreas D Ørskov, Dennis L Hansen, Ingolf Mølle, Daniel T Kristensen, Marianne T Severinsen","doi":"10.1111/bjh.20238","DOIUrl":null,"url":null,"abstract":"<p><p>Treatment-related infertility is of great concern to younger long-term survivors of acute leukaemia (AL). This study aimed to assess birth rates and cumulative incidences of first live birth, use of assisted reproduction technology (ART) and pregnancy outcomes in AL survivors compared to the Danish general population. Patients aged 18-45 years at AL diagnosis, alive and in remission 3 years after the date of diagnosis (index date), were included and matched 1:10 with leukaemia-free comparators on sex, age and parenthood status. A total of 401 AL survivors (183 females; 218 males) and 4010 matched comparators were followed for a median of 9.9 years. The median age at index was 37 years in females and 36 years in males. AL survivors had lower birth rates (incidence rate ratio: 0.77, 95% confidence interval: 0.61-0.99), lower 10-year cumulative incidences (females: 20.1% vs. 27.8%; males: 22.3% vs. 29.9%), a higher use of ART (females: 25.5% vs. 14.1%; males: 55.9% vs. 12.2%), but no higher degree of adverse pregnancy outcomes. This underscores the importance of informing patients of fertility-preservation options as well as of the risk of treatment-related infertility.</p>","PeriodicalId":135,"journal":{"name":"British Journal of Haematology","volume":" ","pages":""},"PeriodicalIF":3.8000,"publicationDate":"2025-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"British Journal of Haematology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/bjh.20238","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Treatment-related infertility is of great concern to younger long-term survivors of acute leukaemia (AL). This study aimed to assess birth rates and cumulative incidences of first live birth, use of assisted reproduction technology (ART) and pregnancy outcomes in AL survivors compared to the Danish general population. Patients aged 18-45 years at AL diagnosis, alive and in remission 3 years after the date of diagnosis (index date), were included and matched 1:10 with leukaemia-free comparators on sex, age and parenthood status. A total of 401 AL survivors (183 females; 218 males) and 4010 matched comparators were followed for a median of 9.9 years. The median age at index was 37 years in females and 36 years in males. AL survivors had lower birth rates (incidence rate ratio: 0.77, 95% confidence interval: 0.61-0.99), lower 10-year cumulative incidences (females: 20.1% vs. 27.8%; males: 22.3% vs. 29.9%), a higher use of ART (females: 25.5% vs. 14.1%; males: 55.9% vs. 12.2%), but no higher degree of adverse pregnancy outcomes. This underscores the importance of informing patients of fertility-preservation options as well as of the risk of treatment-related infertility.
治疗相关性不孕是急性白血病(AL)的年轻长期幸存者非常关注的问题。本研究旨在评估与丹麦普通人群相比,AL幸存者的出生率和首次活产的累计发生率、辅助生殖技术(ART)的使用和妊娠结局。在AL诊断时年龄为18-45岁,在诊断日期(指标日期)后3年存活且缓解的患者被纳入,并在性别、年龄和父母身份方面与无白血病比较者进行1:10匹配。401名AL幸存者(女性183名;218名男性)和4010名匹配的比较者被随访了9.9年。指数中位年龄女性37岁,男性36岁。AL幸存者的出生率较低(发病率比:0.77,95%可信区间:0.61-0.99),10年累积发病率较低(女性:20.1% vs. 27.8%;男性:22.3%对29.9%),更高的ART使用率(女性:25.5%对14.1%;男性:55.9%对12.2%),但没有更高程度的不良妊娠结局。这强调了告知患者保留生育能力的选择以及与治疗相关的不孕症风险的重要性。
期刊介绍:
The British Journal of Haematology publishes original research papers in clinical, laboratory and experimental haematology. The Journal also features annotations, reviews, short reports, images in haematology and Letters to the Editor.